secwatch.observer — SEC 8-K summary
======================================

Issuer:     Organogenesis Holdings Inc. (ORGO)
CIK:        0001661181
Form:       8-K
Filed at:   2024-11-13T23:59:59+00:00
Accession:  0001193125-24-256699
Event type: other_material
Sentiment:  positive
Materiality: 0.80
Item codes: 1.01, 5.03, 2.04, 3.02, 3.03, 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Organogenesis raises $130M convertible preferred, repurchases 7.4M shares, appoints Avista director
--------------------------------------------------------------------------------

- Sold 130,000 shares of Series A Convertible Preferred Stock at $1,000/share for gross proceeds of $130M.
- Net proceeds used for strategic growth, debt repayment, and repurchase of 7.4M common shares from directors at $3.1597/share (~$23.5M).
- Preferred pays 8% annual dividend, compounded quarterly, payable in cash or PIK; conversion price initially $3.7917 (20% premium).
- Company expects to prepay ~$62.5M term loan principal and interest on Nov 13, 2024, using offering proceeds.
- Appointed Garrett Lustig (Avista Principal) to Board, increasing board size to twelve.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1661181/000119312524256699/0001193125-24-256699-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1661181/000119312524256699/d885519d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-256699

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer